Grants and funders

We are grateful for the support of numerous funders who make the work of the Lochmüller Lab possible.

Hanns holds the Canada Research Chair in Neuromuscular Genomics and Health and our lab’s work is supported by funding from the Canada Research Chairs program.

We are supported by a CIHR Foundation Grant on Precision Health for Neuromuscular Diseases under grant no. FDN-167281 and by a CIHR Network Catalyst Grant (jointly funded by Muscular Dystrophy Canada) for NMD4C, a neuromuscular network for Canada, under grant no. NG2-170044. Rachel Thompson holds a CIHR postdoctoral fellowship award under grant no. MFE-171275.

The Canada Foundation for Innovation (CFI) supports equipment in our lab as part of the CRC award.

We are supported by Muscular Dystrophy Canada with a Network Catalyst Grant for NMD4C, a neuromuscular network for Canada (jointly funded by CIHR).

Emily O'Connor's work is supported by a stipend from the French Muscular Dystrophy Association (AFM-Téléthon)

Lochmüller Lab Welcomes New Students

Our lab is growing! We are excited to introduce two new students who have joined the Lochmüller Lab this fall. Kelly Ho Kelly has joined as a Master’s student...

Latest Issue of the Journal of Neuromuscular Diseases Now Available – July 2021

The Journal of Neuromuscular Diseases (JND) has announced the publication of a new issue of the journal! Volume 8, Issue 4 of the JND contains a record number 30 items comprised of research articles, meeting reports...

Meet the Lochmüller Lab Clinical Team

Neuromuscular Clinic for adult patients at The Ottawa Hospital (TOH) Civic Campus As part of the team led by Dr. Jodi Warman Chardon, Hanns sees neuromuscular patients in clinic at...

Special issue of the Journal of Neuromuscular Diseases is devoted to the Treatabolome, designed to shorten diagnosis-to-treatment time for patients with rare diseases

In 2019, as part of the European Solve-RD project, Hanns Lochmüller, Gisèle Bonne and Rachel Thompson launched the Treatabolome, an initiative designed to extract details of effective treatments for rare...

ProDGNE: Research Project to Develop an Innovative Therapeutic Compound to Treat GNE Myopathy

The Lochmüller Lab is proud to share its involvement in ProDGNE , a three-year transnational pre-clinical research project which aims to develop an innovative therapeutic compound to treat GNE Myopathy...

Meet the lab’s two new members

Our lab is growing! We are excited to introduce two new members who have joined the Lochmüller lab this winter. Daniel O'Neil Daniel holds a BSc in Biochemistry from the...

Lochmüller Lab

Hanns Lochmüller and team - research and clinical activities